SI
GILD icon

Sofinnova Investments’s Gilead Sciences GILD Stock Holding History

Sofinnova Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300,000
Closed -$19.4M – 69
2021
Q1 		$19.4M Buy
+300,000
New +$19.3M 1.17% 25
2020
Q2 		– Sell
-100,000
Closed -$7.48M – 83
2020
Q1 		$7.48M Buy
+100,000
New +$6.91M 0.69% 27

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sofinnova Investments's GILD Position: Q4 2025 in Review

Sofinnova Investments sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 1,252,312 shares — an estimated $139M sold.

Sofinnova Investments first reported a position in GILD in Q4 2018 and held it in 7 quarters. The position peaked at $139M in Q3 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Sofinnova Investments reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Sofinnova Investments sold 1,252,312 Gilead Sciences shares in Q4 2025, an estimated $139M.
  • Sofinnova Investments first reported a position in Gilead Sciences in Q4 2018 and held it in 7 quarters.
  • Sofinnova Investments's Gilead Sciences position peaked at $139M in Q3 2025.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Sofinnova Investments's 13F filing for Q4 2025, filed 13 Feb 2026.